Budur Kumar 4
4 · Harmony Biosciences Holdings, Inc. · Filed Jan 26, 2026
Research Summary
AI-generated summary of this filing
Harmony Biosciences CMO Budur Kumar Receives Awards, Exercises Options
What Happened
- Budur Kumar, Chief Medical Officer of Harmony Biosciences (HRMY), was granted awards on Jan 22, 2026 (totaling 54,800 derivative shares: 12,200 and 42,600), and exercised/converted derivatives on Jan 24–25, 2026 (2,188 shares on Jan 24 and 2,662 shares on Jan 25).
- To satisfy required tax withholdings on vesting, the issuer withheld 1,153 shares on Jan 24 (valued at $36.82/share; $42,453) and 1,372 shares on Jan 25 (valued at $36.82/share; $50,517), for a total of 2,525 shares withheld and approximately $92,970 in tax withholding value.
- These transactions are award grants and derivative exercises rather than open‑market sales — withholding of shares for taxes (code F) is routine and does not necessarily indicate a market sale.
Key Details
- Transaction dates and prices:
- Grants (A): Jan 22, 2026 — 12,200 and 42,600 derivative shares (no cash price reported).
- Exercises/Conversions (M): Jan 24, 2026 — 2,188 shares; Jan 25, 2026 — 2,662 shares (no cash reported for exercise conversions).
- Tax withholding (F): Jan 24 — 1,153 shares withheld @ $36.82 = $42,453; Jan 25 — 1,372 shares withheld @ $36.82 = $50,517.
- Net shares related to these exercises: 4,850 shares were exercised/converted and 2,525 shares were withheld for taxes (leaving 2,325 shares net delivered to the insider from these conversions, based on the reported entries).
- Shares owned after the transactions: not specified in the filing.
- Footnotes of note:
- F1: Withheld shares were used to satisfy required income tax withholdings upon RSU vesting.
- F2–F5: Describe vesting schedules — some awards/options vest over multi‑year schedules (25% after one year or annual/quarterly vesting over four years) and reference prior grant dates (Jan 24, 2024; Jan 25, 2025).
- Filing timeliness: Report period begins Jan 22, 2026 and the Form 4 was filed Jan 26, 2026 — the filing appears timely (not marked late).
Context
- These entries reflect awards (likely restricted stock units and/or option grants) and the exercise/conversion of derivatives, with the company withholding a portion of shares to satisfy tax obligations (a common, non‑market cashless method).
- Because the transactions involve vested awards and withholding for taxes rather than open‑market sales, they generally represent administrative settlement of compensation rather than a directional bet by the insider.
Insider Transaction Report
Form 4
Budur Kumar
CHIEF MEDICAL OFFICER
Transactions
- Award
Restricted Stock Units
[F3]2026-01-22+12,200→ 12,200 total→ Common Stock (12,200 underlying) - Exercise/Conversion
Common Stock
2026-01-24+2,188→ 2,188 total - Tax Payment
Common Stock
[F1]2026-01-24$36.82/sh−1,153$42,453→ 1,035 total - Exercise/Conversion
Common Stock
2026-01-25+2,662→ 2,662 total - Tax Payment
Common Stock
[F1]2026-01-25$36.82/sh−1,372$50,517→ 1,290 total - Award
Stock Option
[F2]2026-01-22+42,600→ 42,600 totalExercise: $36.76Exp: 2036-01-22→ Common Stock (42,600 underlying) - Exercise/Conversion
Restricted Stock Units
[F4]2026-01-24−2,188→ 4,175 total→ Common Stock (2,188 underlying) - Exercise/Conversion
Restricted Stock Units
[F5]2026-01-25−2,662→ 7,988 total→ Common Stock (2,662 underlying)
Footnotes (5)
- [F1]Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
- [F2]The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- [F3]The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- [F4]This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- [F5]This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Signature
/s/ Christian Ulrich, Attorney-in-Fact|2026-01-26